What is the main reason you are considering medical cannabis?
What state do you live in?
Enter your email to see your results.
By signing up you agree to receive marketing emails from NuggMD. Don't worry, your email is safe with us.
Great news, your condition often qualifies for medical cannabis! Speak with a NuggMD doctor today to be sure. You'll only pay if approved, there’s no appointment required, and we're open from 8am to 10pm daily.
Great news, your condition often qualifies for medical cannabis! But you might need a qualified caregiver. Speak with a NuggMD doctor today to be sure. You'll only pay for your evaluation if you are approved! No appointment is required, and we're open from 8am to 10pm daily.
Your state doesn't currently allow medical cannabis. Follow the link below to read more about cannabis laws in your state.
We're sorry, but we can't determine your eligibility. Please try later.
What is the main reason you are considering medical cannabis?
What state do you live in?
Enter your email to see your results.
By signing up you agree to receive marketing emails from NuggMD. Don't worry, your email is safe with us.
Great news, your condition often qualifies for medical cannabis! Speak with a NuggMD doctor today to be sure. You'll only pay if approved, there’s no appointment required, and we're open from 8am to 10pm daily.
Great news, your condition often qualifies for medical cannabis! But you might need a qualified caregiver. Speak with a NuggMD doctor today to be sure. You'll only pay for your evaluation if you are approved! No appointment is required, and we're open from 8am to 10pm daily.
Your state doesn't currently allow medical cannabis. Follow the link below to read more about cannabis laws in your state.
We're sorry, but we can't determine your eligibility. Please try later.
Q1: "Would you pay a premium for cannabis that’s cultivated, distributed, and sold by small, independent businesses as opposed to large, multi-state cannabis companies?"
n:
%
Yes
309
51%
I would consider it
254
42%
No
39
6%
602
Q2: "How effective is cannabis, when used in your spare time, in helping you deal with work-related stress or anxiety?"
n:
%
Very effective
429
71%
Mildly effective
78
13%
Not sufficiently effective
3
0%
Not applicable - I do not use cannabis for that purpose
92
15%
602
Q4: "Where do you prefer to consume cannabis?"
n:
%
At home
529
88%
Someplace else
4
1%
No preference
69
11%
602
Q5: "If you could vape in more public places, would you vape cannabis more often?"
n:
%
Yes, a lot more
87
14%
Yes, a bit more
178
30%
No change
202
34%
Not applicable - I don't use vapes and have no desire to start
135
22%
602
Q6: "How interested are you in cannabis products that add other cannabinoids, such as CBG, CBN, or CBD, to THC for therapeutic or wellness reasons?"
n:
%
Very interested
301
50%
Moderately interested
157
26%
Slightly interested
92
15%
Not interested
52
9%
602
Q7: "How frequently do you:"
Daily
Multiple times per week
Weekly
Monthly
Yearly
Never
Drink coffee
62.0%
7.5%
6.0%
4.0%
2.5%
18.1%
Exercise
27.4%
34.9%
19.6%
7.0%
1.2%
10.0%
Drink alcohol
6.1%
11.3%
20.3%
16.1%
15.3%
30.9%
Go to a movie theater
1.5%
3.0%
11.3%
13.1%
38.4%
32.7%
Take nutritional supplements
54.5%
10.3%
9.5%
3.8%
3.2%
18.8%
Eat fast food
1.5%
11.5%
29.4%
27.9%
15.4%
14.3%
Order food or grocery delivery
3.3%
8.3%
23.9%
19.9%
9.0%
35.5%
Methodology
The NuggMD Cannabis Consumer Poll surveys a validated, representative sample of 1.2+ million cannabis consumers who live in state-legal markets. The poll was conducted from May 19 to June 3, 2025.
n (sample size)
602
Respondents from sample
z-score
1.96
95% confidence level
Margin of error (+/-)
3.99%
NuggMD conducts cannabis consumer polls using first-party data. Roughly half of the sample reports using cannabis mostly or exclusively for medical reasons, while the remainder reports some degree of recreational use. Bear in mind that there is no single source of truth for what constitutes medical versus recreational use beyond the self-selection of the consumer.
Additionally, a majority of the sample reports daily cannabis consumption. It is therefore advisable to assume our polling is over-indexed on medical users and frequent users. The perceptions and behaviors of our sample is likely to be a leading indicator of how the consumer market will trend.
Full data set and demographic break-out available upon request.
An influential House of Representatives legislative committee last week voted to block the Trump administration from reclassifying cannabis under federal drug laws.